Wynn Capital LLC Invests $1.98 Million in McKesson Co. (NYSE:MCK)

Wynn Capital LLC purchased a new stake in shares of McKesson Co. (NYSE:MCK) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 4,272 shares of the company’s stock, valued at approximately $1,978,000. McKesson makes up about 1.6% of Wynn Capital LLC’s investment portfolio, making the stock its 14th biggest position.

Other large investors have also added to or reduced their stakes in the company. Raymond James & Associates grew its holdings in shares of McKesson by 6.1% in the fourth quarter. Raymond James & Associates now owns 153,180 shares of the company’s stock worth $70,919,000 after purchasing an additional 8,784 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in McKesson by 6.8% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 85,779 shares of the company’s stock valued at $39,714,000 after acquiring an additional 5,425 shares during the period. Insight Wealth Strategies LLC purchased a new position in McKesson in the 4th quarter valued at $1,813,000. Aspire Private Capital LLC raised its holdings in shares of McKesson by 3.2% during the 3rd quarter. Aspire Private Capital LLC now owns 1,957 shares of the company’s stock worth $851,000 after acquiring an additional 60 shares during the period. Finally, Argus Investors Counsel Inc. purchased a new position in shares of McKesson during the 4th quarter worth $891,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on MCK shares. SVB Leerink initiated coverage on shares of McKesson in a research note on Monday, February 26th. They set an “outperform” rating and a $600.00 target price on the stock. Barclays assumed coverage on McKesson in a research note on Wednesday, January 3rd. They issued an “overweight” rating and a $537.00 price objective on the stock. UBS Group lifted their price objective on McKesson from $575.00 to $620.00 and gave the stock a “buy” rating in a report on Wednesday, March 6th. StockNews.com lowered McKesson from a “strong-buy” rating to a “buy” rating in a research report on Thursday, January 4th. Finally, Morgan Stanley upped their price objective on McKesson from $522.00 to $548.00 and gave the company an “overweight” rating in a report on Monday, April 15th. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $533.50.

Insider Activity

In related news, EVP Leann B. Smith sold 186 shares of McKesson stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total value of $92,256.00. Following the completion of the transaction, the executive vice president now owns 1,511 shares in the company, valued at $749,456. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other McKesson news, EVP Leann B. Smith sold 186 shares of the company’s stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total value of $92,256.00. Following the transaction, the executive vice president now directly owns 1,511 shares in the company, valued at approximately $749,456. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Brian S. Tyler sold 3,473 shares of the stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $524.55, for a total transaction of $1,821,762.15. Following the sale, the chief executive officer now directly owns 43,445 shares of the company’s stock, valued at approximately $22,789,074.75. The disclosure for this sale can be found here. Company insiders own 0.21% of the company’s stock.

McKesson Trading Up 0.7 %

MCK stock traded up $3.55 on Wednesday, hitting $535.56. The company had a trading volume of 418,139 shares, compared to its average volume of 687,556. McKesson Co. has a 12-month low of $352.34 and a 12-month high of $543.00. The stock has a market cap of $70.38 billion, a price-to-earnings ratio of 24.10, a P/E/G ratio of 1.43 and a beta of 0.45. The stock’s 50-day simple moving average is $526.12 and its 200 day simple moving average is $488.15.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, February 7th. The company reported $7.74 EPS for the quarter, beating the consensus estimate of $7.05 by $0.69. The business had revenue of $80.90 billion during the quarter, compared to analyst estimates of $77.93 billion. McKesson had a net margin of 0.99% and a negative return on equity of 262.63%. The company’s quarterly revenue was up 14.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.90 EPS. Research analysts forecast that McKesson Co. will post 27.59 earnings per share for the current year.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, July 1st. Shareholders of record on Monday, June 3rd will be given a dividend of $0.62 per share. This represents a $2.48 dividend on an annualized basis and a yield of 0.46%. McKesson’s dividend payout ratio is presently 11.24%.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.